Evidence map›Paper›PMID 34380706›Full record

ArticleDiabetes care2021

The Beneficial Effects of Earlier Versus Later Implementation of Intensive Therapy in Type 1 Diabetes.

John M Lachin, Ionut Bebu, David M Nathan, DCCT/EDIC Research Group

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Review
  13. An overview of insulin therapy for the non-specialist.Diabetes, obesity & metabolism · 2025
    Review
  14. Review
  15. Article
  16. European Survey on Adults with Type 1 Diabetes and their Caregivers: Insights into Personal Experience and Needs for Improving Diabetes Care.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. 12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

John M LachinThe Biostatistics Center, George Washington University, Rockville, MD jml@bsc.gwu.edu.ORCID https://orcid.org/0000-0001-9838-2841
Ionut BebuThe Biostatistics Center, George Washington University, Rockville, MD.ORCID https://orcid.org/0000-0002-4944-7968
David M Nathan
DCCT/EDIC Research Group
George Washington University · USHarvard University · US

Funding

Limited Competition for the Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Clinical Research Center (Collaborative U01)U01DK094157 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Ionut Bebu, Barbara Halina Braffett · 2011 to 2026
$97.6M
Epidemiology of Diabetes Interventions and Complications Data Coordinating CenterU01DK094176 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BEBU, IONUT, BRAFFETT, BARBARA HALINA · 2012 to 2022
$30.8M
Residual Beta Cell Function in Patients with Long-Term Type 1 DiabetesDP3DK104438 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GUBITOSI-KLUG, ROSE A · 2014 to 2014
$2.5M
NIDDK NIH HHS DP3 DK104438NIDDK NIH HHS U01 DK094157NIDDK NIH HHS U01 DK094176
6 · The paper itself

Abstract

objectiveThe principal aim is to estimate the benefits of earlier versus later implementation of intensive therapy in type 1 diabetes with respect to the long-term risks of progression of a renal (microvascular) and cardiovascular (macrovascular) complication in the Epidemiology of Diabetes Interventions and Complications (EDIC) study. RESEARCH DESIGN AND

methodsCox proportional hazards regression models estimated the 20-year cumulative incidence (absolute risk) and the 20-year relative risk of cardiovascular disease (CVD) and reduced estimated glomerular filtration rate (eGFR) over the first 20 years of EDIC follow-up as a function of the mean HbA

resultsA hypothetical patient treated earlier with 10 years of intensive therapy and a mean HbA

conclusionsWhile implementation of intensive therapy at any time in type 1 diabetes will be beneficial, within the 20-year period modeled, earlier relative to later implementation is associated with a greater reduction in the risks of kidney and cardiovascular complications.

Identifiers

PMID34380706
PMCPMC8929189
OpenAlexW3187495758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.